In our study, PSA was not selected for predicting pECE, which is dissimilar from the specifications of existing classical cancer nomograms extensively used in the literature, such as Cancer of the Prostate Risk Assessment (CAPRA), Partin tables, and the Memorial Sloan Kettering Cancer Center (MSKCC) nomogram [21–23]. The gene discussed is KLK3; the disease is cancer.